OPIANT PHARMACEUTICALS, INC. Annual Revenues in USD from 2011 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Revenues history and growth rate from 2011 to 2021.
  • Opiant Pharmaceuticals, Inc. Revenues for the quarter ending September 30, 2022 was $174K, a 98.9% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. Revenues for the twelve months ending September 30, 2022 was $22.3M, a 49.1% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. annual Revenues for 2021 was $47.8M, a 61.3% increase from 2020.
  • Opiant Pharmaceuticals, Inc. annual Revenues for 2020 was $29.6M.
  • Opiant Pharmaceuticals, Inc. annual Revenues for 2018 was $14M, a 10.1% decline from 2017.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $47.8M +$18.2M +61.3% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-15
2020 $29.6M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2018 $14M -$1.57M -10.1% Jan 1, 2018 Dec 31, 2018 10-K 2019-03-21
2017 $15.6M +$5.65M +57.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-21
2016 $9.9M +$8.35M +539% Aug 1, 2015 Jul 31, 2016 10-KT 2018-03-07
2015 $1.55M Aug 1, 2014 Jul 31, 2015 10-K 2016-10-28
2012 $0 $0 Aug 1, 2011 Jul 31, 2012 10-K/A 2012-11-01
2011 $0 Aug 1, 2010 Jul 31, 2011 10-K/A 2012-11-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.